nodes	percent_of_prediction	percent_of_DWPC	metapath
Azelastine—HRH3—narcolepsy	0.957	1	CbGaD
Azelastine—HRH1—Histamine receptors—HRH3—narcolepsy	0.00355	0.0865	CbGpPWpGaD
Azelastine—Clozapine—HRH3—narcolepsy	0.00137	0.667	CrCbGaD
Azelastine—HRH3—Amine ligand-binding receptors—HTR2A—narcolepsy	0.000833	0.0203	CbGpPWpGaD
Azelastine—HRH3—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.000703	0.0171	CbGpPWpGaD
Azelastine—HRH3—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.000703	0.0171	CbGpPWpGaD
Azelastine—HRH3—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.000679	0.0165	CbGpPWpGaD
Azelastine—ADRA1B—Amine ligand-binding receptors—HRH3—narcolepsy	0.00061	0.0149	CbGpPWpGaD
Azelastine—HRH3—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.000602	0.0147	CbGpPWpGaD
Azelastine—HRH3—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.000602	0.0147	CbGpPWpGaD
Azelastine—HRH3—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.000582	0.0142	CbGpPWpGaD
Azelastine—ADRA1B—AMPK Signaling—CPT1B—narcolepsy	0.000569	0.0139	CbGpPWpGaD
Azelastine—HRH3—G alpha (i) signalling events—PENK—narcolepsy	0.000554	0.0135	CbGpPWpGaD
Azelastine—HRH1—Amine ligand-binding receptors—HRH3—narcolepsy	0.000552	0.0134	CbGpPWpGaD
Azelastine—HRH3—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.000495	0.012	CbGpPWpGaD
Azelastine—HRH3—GPCR ligand binding—HCRTR2—narcolepsy	0.000459	0.0112	CbGpPWpGaD
Azelastine—HRH3—GPCR ligand binding—HCRTR1—narcolepsy	0.000459	0.0112	CbGpPWpGaD
Azelastine—HRH3—GPCR ligand binding—P2RY11—narcolepsy	0.000443	0.0108	CbGpPWpGaD
Azelastine—HRH3—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.000441	0.0107	CbGpPWpGaD
Azelastine—HRH3—Monoamine Transport—TNF—narcolepsy	0.000437	0.0106	CbGpPWpGaD
Azelastine—HRH3—GPCR ligand binding—HCRT—narcolepsy	0.000377	0.00917	CbGpPWpGaD
Azelastine—HRH3—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.000375	0.00913	CbGpPWpGaD
Azelastine—Loxapine—HTR2A—narcolepsy	0.000371	0.181	CrCbGaD
Azelastine—ADRA1B—Monoamine GPCRs—HTR2A—narcolepsy	0.000362	0.00881	CbGpPWpGaD
Azelastine—HRH3—GPCR ligand binding—PENK—narcolepsy	0.000336	0.00818	CbGpPWpGaD
Azelastine—ADRA1B—G alpha (q) signalling events—HCRTR1—narcolepsy	0.000332	0.00808	CbGpPWpGaD
Azelastine—ADRA1B—G alpha (q) signalling events—HCRTR2—narcolepsy	0.000332	0.00808	CbGpPWpGaD
Azelastine—HRH1—Monoamine GPCRs—HTR2A—narcolepsy	0.000327	0.00797	CbGpPWpGaD
Azelastine—ADRA1B—G alpha (q) signalling events—P2RY11—narcolepsy	0.000321	0.00781	CbGpPWpGaD
Azelastine—Clozapine—HTR2A—narcolepsy	0.000312	0.152	CrCbGaD
Azelastine—ADRA1B—Amine ligand-binding receptors—HTR2A—narcolepsy	0.000304	0.0074	CbGpPWpGaD
Azelastine—HRH1—G alpha (q) signalling events—HCRTR2—narcolepsy	0.0003	0.00732	CbGpPWpGaD
Azelastine—HRH1—G alpha (q) signalling events—HCRTR1—narcolepsy	0.0003	0.00732	CbGpPWpGaD
Azelastine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.000297	0.00723	CbGpPWpGaD
Azelastine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.000297	0.00723	CbGpPWpGaD
Azelastine—KCNH2—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.00029	0.00707	CbGpPWpGaD
Azelastine—HRH1—G alpha (q) signalling events—P2RY11—narcolepsy	0.00029	0.00707	CbGpPWpGaD
Azelastine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.000287	0.00698	CbGpPWpGaD
Azelastine—HRH3—GPCR ligand binding—TRH—narcolepsy	0.000285	0.00695	CbGpPWpGaD
Azelastine—HRH1—Amine ligand-binding receptors—HTR2A—narcolepsy	0.000275	0.0067	CbGpPWpGaD
Azelastine—ADRA1B—G alpha (q) signalling events—HCRT—narcolepsy	0.000273	0.00664	CbGpPWpGaD
Azelastine—HRH3—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000272	0.00663	CbGpPWpGaD
Azelastine—HRH3—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000272	0.00663	CbGpPWpGaD
Azelastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.000269	0.00654	CbGpPWpGaD
Azelastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.000269	0.00654	CbGpPWpGaD
Azelastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.00026	0.00632	CbGpPWpGaD
Azelastine—HRH3—GPCR downstream signaling—HCRTR2—narcolepsy	0.000259	0.00631	CbGpPWpGaD
Azelastine—HRH3—GPCR downstream signaling—HCRTR1—narcolepsy	0.000259	0.00631	CbGpPWpGaD
Azelastine—ADRA1B—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.000257	0.00625	CbGpPWpGaD
Azelastine—ADRA1B—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.000257	0.00625	CbGpPWpGaD
Azelastine—HRH3—GPCR downstream signaling—P2RY11—narcolepsy	0.00025	0.0061	CbGpPWpGaD
Azelastine—ADRA1B—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.000248	0.00603	CbGpPWpGaD
Azelastine—HRH1—G alpha (q) signalling events—HCRT—narcolepsy	0.000247	0.00601	CbGpPWpGaD
Azelastine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.000244	0.00594	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—HCRTR2—narcolepsy	0.000235	0.00573	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—HCRTR1—narcolepsy	0.000235	0.00573	CbGpPWpGaD
Azelastine—HRH1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.000232	0.00566	CbGpPWpGaD
Azelastine—HRH1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.000232	0.00566	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—P2RY11—narcolepsy	0.000227	0.00554	CbGpPWpGaD
Azelastine—HRH1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.000224	0.00546	CbGpPWpGaD
Azelastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.000221	0.00537	CbGpPWpGaD
Azelastine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00022	0.00535	CbGpPWpGaD
Azelastine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00022	0.00535	CbGpPWpGaD
Azelastine—HRH3—GPCR downstream signaling—HCRT—narcolepsy	0.000213	0.00518	CbGpPWpGaD
Azelastine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.000212	0.00517	CbGpPWpGaD
Azelastine—HRH3—GPCR ligand binding—NPS—narcolepsy	0.000207	0.00505	CbGpPWpGaD
Azelastine—HRH3—GPCR ligand binding—TAC1—narcolepsy	0.000207	0.00505	CbGpPWpGaD
Azelastine—ADRA1B—G alpha (q) signalling events—TRH—narcolepsy	0.000207	0.00503	CbGpPWpGaD
Azelastine—HRH1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.000199	0.00485	CbGpPWpGaD
Azelastine—HRH1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.000199	0.00485	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—HCRT—narcolepsy	0.000193	0.00471	CbGpPWpGaD
Azelastine—HRH1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.000192	0.00468	CbGpPWpGaD
Azelastine—HRH3—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000191	0.00466	CbGpPWpGaD
Azelastine—HRH3—GPCR downstream signaling—PENK—narcolepsy	0.00019	0.00462	CbGpPWpGaD
Azelastine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CPT1B—narcolepsy	0.000189	0.0046	CbGpPWpGaD
Azelastine—HRH1—G alpha (q) signalling events—TRH—narcolepsy	0.000187	0.00455	CbGpPWpGaD
Azelastine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.000185	0.0045	CbGpPWpGaD
Azelastine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.000181	0.0044	CbGpPWpGaD
Azelastine—KCNH2—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.000175	0.00425	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—PENK—narcolepsy	0.000172	0.0042	CbGpPWpGaD
Azelastine—ADRA1B—GPCR ligand binding—HCRTR2—narcolepsy	0.000167	0.00408	CbGpPWpGaD
Azelastine—ADRA1B—GPCR ligand binding—HCRTR1—narcolepsy	0.000167	0.00408	CbGpPWpGaD
Azelastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.000167	0.00407	CbGpPWpGaD
Azelastine—HRH3—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000164	0.00399	CbGpPWpGaD
Azelastine—HRH1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.000163	0.00398	CbGpPWpGaD
Azelastine—ADRA1B—GPCR ligand binding—P2RY11—narcolepsy	0.000162	0.00394	CbGpPWpGaD
Azelastine—HRH3—GPCR downstream signaling—TRH—narcolepsy	0.000161	0.00393	CbGpPWpGaD
Azelastine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.000161	0.00392	CbGpPWpGaD
Azelastine—HRH1—GPCR ligand binding—HCRTR1—narcolepsy	0.000152	0.00369	CbGpPWpGaD
Azelastine—HRH1—GPCR ligand binding—HCRTR2—narcolepsy	0.000152	0.00369	CbGpPWpGaD
Azelastine—ADRA1B—G alpha (q) signalling events—NPS—narcolepsy	0.00015	0.00366	CbGpPWpGaD
Azelastine—ADRA1B—G alpha (q) signalling events—TAC1—narcolepsy	0.00015	0.00366	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—TRH—narcolepsy	0.000146	0.00357	CbGpPWpGaD
Azelastine—HRH1—GPCR ligand binding—P2RY11—narcolepsy	0.000146	0.00356	CbGpPWpGaD
Azelastine—HRH1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.000146	0.00355	CbGpPWpGaD
Azelastine—ADRA1B—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00014	0.00341	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—HCRTR1—narcolepsy	0.000139	0.00339	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—HCRTR2—narcolepsy	0.000139	0.00339	CbGpPWpGaD
Azelastine—ADRA1B—GPCR ligand binding—HCRT—narcolepsy	0.000137	0.00335	CbGpPWpGaD
Azelastine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.000137	0.00333	CbGpPWpGaD
Azelastine—HRH1—G alpha (q) signalling events—NPS—narcolepsy	0.000136	0.00331	CbGpPWpGaD
Azelastine—HRH1—G alpha (q) signalling events—TAC1—narcolepsy	0.000136	0.00331	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—P2RY11—narcolepsy	0.000134	0.00327	CbGpPWpGaD
Azelastine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.000134	0.00327	CbGpPWpGaD
Azelastine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.000134	0.00327	CbGpPWpGaD
Azelastine—ABCB1—Allograft Rejection—HLA-DQA1—narcolepsy	0.000131	0.0032	CbGpPWpGaD
Azelastine—HRH1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.000127	0.00309	CbGpPWpGaD
Azelastine—HRH3—GPCR ligand binding—HTR2A—narcolepsy	0.000125	0.00304	CbGpPWpGaD
Azelastine—HRH1—GPCR ligand binding—HCRT—narcolepsy	0.000124	0.00303	CbGpPWpGaD
Azelastine—HRH1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.000124	0.00302	CbGpPWpGaD
Azelastine—ABCB1—Allograft Rejection—HLA-DQB1—narcolepsy	0.000123	0.00299	CbGpPWpGaD
Azelastine—ADRA1B—GPCR ligand binding—PENK—narcolepsy	0.000123	0.00298	CbGpPWpGaD
Azelastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.000122	0.00296	CbGpPWpGaD
Azelastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.000122	0.00296	CbGpPWpGaD
Azelastine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00012	0.00292	CbGpPWpGaD
Azelastine—HRH3—GPCR downstream signaling—TAC1—narcolepsy	0.000117	0.00285	CbGpPWpGaD
Azelastine—HRH3—GPCR downstream signaling—NPS—narcolepsy	0.000117	0.00285	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—HCRT—narcolepsy	0.000114	0.00278	CbGpPWpGaD
Azelastine—HRH1—GPCR ligand binding—PENK—narcolepsy	0.000111	0.0027	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000111	0.00269	CbGpPWpGaD
Azelastine—HRH1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000109	0.00264	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—TAC1—narcolepsy	0.000106	0.00259	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—NPS—narcolepsy	0.000106	0.00259	CbGpPWpGaD
Azelastine—ADRA1B—GPCR ligand binding—TRH—narcolepsy	0.000104	0.00254	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—PENK—narcolepsy	0.000102	0.00248	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000101	0.00247	CbGpPWpGaD
Azelastine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	9.94e-05	0.00242	CbGpPWpGaD
Azelastine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	9.94e-05	0.00242	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—HCRTR2—narcolepsy	9.46e-05	0.0023	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—HCRTR1—narcolepsy	9.46e-05	0.0023	CbGpPWpGaD
Azelastine—HRH1—GPCR ligand binding—TRH—narcolepsy	9.43e-05	0.0023	CbGpPWpGaD
Azelastine—ABCB1—Allograft Rejection—HLA-DRB1—narcolepsy	9.34e-05	0.00227	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—P2RY11—narcolepsy	9.14e-05	0.00222	CbGpPWpGaD
Azelastine—ADRA1B—GPCR ligand binding—HRH3—narcolepsy	9.13e-05	0.00222	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	9.05e-05	0.0022	CbGpPWpGaD
Azelastine—ADRA1B—G alpha (q) signalling events—HTR2A—narcolepsy	9.03e-05	0.0022	CbGpPWpGaD
Azelastine—HRH1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	9e-05	0.00219	CbGpPWpGaD
Azelastine—HRH1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	9e-05	0.00219	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—TRH—narcolepsy	8.65e-05	0.00211	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—HCRTR2—narcolepsy	8.59e-05	0.00209	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—HCRTR1—narcolepsy	8.59e-05	0.00209	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—HCRTR1—narcolepsy	8.56e-05	0.00209	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—HCRTR2—narcolepsy	8.56e-05	0.00209	CbGpPWpGaD
Azelastine—CYP1A1—Aryl Hydrocarbon Receptor—TNF—narcolepsy	8.52e-05	0.00207	CbGpPWpGaD
Azelastine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	8.52e-05	0.00207	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—P2RY11—narcolepsy	8.3e-05	0.00202	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—P2RY11—narcolepsy	8.27e-05	0.00201	CbGpPWpGaD
Azelastine—HRH1—GPCR ligand binding—HRH3—narcolepsy	8.27e-05	0.00201	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	8.25e-05	0.00201	CbGpPWpGaD
Azelastine—HRH1—G alpha (q) signalling events—HTR2A—narcolepsy	8.17e-05	0.00199	CbGpPWpGaD
Azelastine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	8.08e-05	0.00197	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—HCRTR2—narcolepsy	7.78e-05	0.00189	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—HCRTR1—narcolepsy	7.78e-05	0.00189	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—HCRT—narcolepsy	7.77e-05	0.00189	CbGpPWpGaD
Azelastine—ADRA1B—GPCR ligand binding—NPS—narcolepsy	7.57e-05	0.00184	CbGpPWpGaD
Azelastine—ADRA1B—GPCR ligand binding—TAC1—narcolepsy	7.57e-05	0.00184	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	7.52e-05	0.00183	CbGpPWpGaD
Azelastine—KCNH2—SIDS Susceptibility Pathways—TNF—narcolepsy	7.51e-05	0.00183	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—P2RY11—narcolepsy	7.51e-05	0.00183	CbGpPWpGaD
Azelastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	7.31e-05	0.00178	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—HCRT—narcolepsy	7.05e-05	0.00172	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	7.05e-05	0.00172	CbGpPWpGaD
Azelastine—HRH3—GPCR downstream signaling—HTR2A—narcolepsy	7.05e-05	0.00172	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—HCRT—narcolepsy	7.03e-05	0.00171	CbGpPWpGaD
Azelastine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	6.98e-05	0.0017	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—PENK—narcolepsy	6.92e-05	0.00169	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	6.89e-05	0.00168	CbGpPWpGaD
Azelastine—HRH1—GPCR ligand binding—NPS—narcolepsy	6.85e-05	0.00167	CbGpPWpGaD
Azelastine—HRH1—GPCR ligand binding—TAC1—narcolepsy	6.85e-05	0.00167	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—CHKB—narcolepsy	6.61e-05	0.00161	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—HTR2A—narcolepsy	6.4e-05	0.00156	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—HCRT—narcolepsy	6.39e-05	0.00156	CbGpPWpGaD
Azelastine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	6.32e-05	0.00154	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—NPS—narcolepsy	6.29e-05	0.00153	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—TAC1—narcolepsy	6.29e-05	0.00153	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—PENK—narcolepsy	6.29e-05	0.00153	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—PENK—narcolepsy	6.27e-05	0.00153	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	6.15e-05	0.0015	CbGpPWpGaD
Azelastine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	5.98e-05	0.00146	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—TRH—narcolepsy	5.89e-05	0.00143	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—PENK—narcolepsy	5.69e-05	0.00139	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	5.61e-05	0.00137	CbGpPWpGaD
Azelastine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	5.43e-05	0.00132	CbGpPWpGaD
Azelastine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—narcolepsy	5.43e-05	0.00132	CbGpPWpGaD
Azelastine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	5.41e-05	0.00132	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—TRH—narcolepsy	5.35e-05	0.0013	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—CHKB—narcolepsy	5.33e-05	0.0013	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—TRH—narcolepsy	5.33e-05	0.0013	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—CHKB—narcolepsy	5.22e-05	0.00127	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—CHKB—narcolepsy	5.21e-05	0.00127	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—HRH3—narcolepsy	5.16e-05	0.00126	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—HCRTR2—narcolepsy	5.07e-05	0.00124	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—HCRTR1—narcolepsy	5.07e-05	0.00124	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—CHKB—narcolepsy	4.93e-05	0.0012	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—P2RY11—narcolepsy	4.9e-05	0.00119	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—TRH—narcolepsy	4.84e-05	0.00118	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	4.79e-05	0.00117	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—HRH3—narcolepsy	4.69e-05	0.00114	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—HRH3—narcolepsy	4.67e-05	0.00114	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—HCRTR2—narcolepsy	4.59e-05	0.00112	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—HCRTR1—narcolepsy	4.59e-05	0.00112	CbGpPWpGaD
Azelastine—ADRA1B—GPCR ligand binding—HTR2A—narcolepsy	4.55e-05	0.00111	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—CHKB—narcolepsy	4.52e-05	0.0011	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—CPT1B—narcolepsy	4.49e-05	0.00109	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—P2RY11—narcolepsy	4.44e-05	0.00108	CbGpPWpGaD
Azelastine—ABCB1—Allograft Rejection—TNF—narcolepsy	4.41e-05	0.00108	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—NPS—narcolepsy	4.28e-05	0.00104	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—TAC1—narcolepsy	4.28e-05	0.00104	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—HRH3—narcolepsy	4.24e-05	0.00103	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—HCRT—narcolepsy	4.17e-05	0.00101	CbGpPWpGaD
Azelastine—HRH1—GPCR ligand binding—HTR2A—narcolepsy	4.12e-05	0.001	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—CHKB—narcolepsy	4.03e-05	0.000982	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—CHKB—narcolepsy	3.93e-05	0.000958	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—NPS—narcolepsy	3.88e-05	0.000946	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—TAC1—narcolepsy	3.88e-05	0.000946	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—NPS—narcolepsy	3.87e-05	0.000943	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—TAC1—narcolepsy	3.87e-05	0.000943	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—HTR2A—narcolepsy	3.78e-05	0.000921	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—HCRT—narcolepsy	3.77e-05	0.000919	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PENK—narcolepsy	3.71e-05	0.000905	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CHKB—narcolepsy	3.71e-05	0.000903	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CHKB—narcolepsy	3.68e-05	0.000895	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—CPT1B—narcolepsy	3.63e-05	0.000883	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—CPT1B—narcolepsy	3.55e-05	0.000865	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—CPT1B—narcolepsy	3.54e-05	0.000863	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—TAC1—narcolepsy	3.52e-05	0.000856	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—NPS—narcolepsy	3.52e-05	0.000856	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PENK—narcolepsy	3.36e-05	0.000819	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—CPT1B—narcolepsy	3.35e-05	0.000815	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—TRH—narcolepsy	3.16e-05	0.000769	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CHKB—narcolepsy	3.14e-05	0.000765	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—CPT1B—narcolepsy	3.07e-05	0.000748	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—TRH—narcolepsy	2.86e-05	0.000696	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—HRH3—narcolepsy	2.77e-05	0.000674	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—CPT1B—narcolepsy	2.74e-05	0.000667	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—CPT1B—narcolepsy	2.67e-05	0.000651	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—HTR2A—narcolepsy	2.57e-05	0.000627	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CPT1B—narcolepsy	2.52e-05	0.000614	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—HRH3—narcolepsy	2.51e-05	0.00061	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CPT1B—narcolepsy	2.5e-05	0.000608	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CHKB—narcolepsy	2.42e-05	0.00059	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—HTR2A—narcolepsy	2.34e-05	0.000569	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—HTR2A—narcolepsy	2.33e-05	0.000567	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—TAC1—narcolepsy	2.29e-05	0.000559	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—NPS—narcolepsy	2.29e-05	0.000559	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	2.18e-05	0.000531	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CPT1B—narcolepsy	2.13e-05	0.00052	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—HTR2A—narcolepsy	2.12e-05	0.000515	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—TAC1—narcolepsy	2.08e-05	0.000506	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—NPS—narcolepsy	2.08e-05	0.000506	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CPT1B—narcolepsy	1.65e-05	0.000401	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—HTR2A—narcolepsy	1.38e-05	0.000336	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—HTR2A—narcolepsy	1.25e-05	0.000304	CbGpPWpGaD
